Physician profile
Ella Wright
NPI 1891170007
$1,188.16
in general payments reported to CMS, 2019-2025
18 companies · $172 in 2025
The $172 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $502 · 2022: $287 · 2023: $198 · 2024: $29.45 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $399.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $223.81 | 2022-2025 | Farxiga, Breztri |
| Merck Sharp & Dohme LLC | $138.04 | 2021-2025 | Verquvo |
| Lilly USA, LLC | $114.93 | 2021-2023 | Mounjaro |
| Pfizer INC. | $87.33 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.92 | 2021-2025 | Jardiance |
| Abbvie INC. | $78.95 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $76.52 | 2021-2024 | |
| Welch Allyn | $64.38 | 2021 | |
| Baxter Healthcare | $64.38 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $61.35 | 2021-2023 | Trintellix |
| Abbott Laboratories | $46.42 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $32.61 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $30.86 | 2025 | |
| Xeris Pharmaceuticals, INC. | $20.03 | 2022 | |
| Eisai INC. | $19.30 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $18.21 | 2023 | Xarelto |
| Kowa Pharmaceuticals America, INC. | $15.65 | 2025 | Zoryve |
| Novo Nordisk INC | $12.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ella Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.